ClaimFortis Technologies

PILOT DISCUSSION SUMMARY

A focused pilot for stronger denial responses.

Evaluate appeal preparation within an existing provider or revenue-cycle operation: one provider group, one payer, and one denial category.

Proposed evaluation · Scope agreed before engagementOctober 5, 2026

The question to test

Can reviewed denial-response knowledge help the team respond sooner and reduce total handling effort while maintaining evidence support, packet quality, and customer control?

What the partner provides

  • A workflow owner, technical lead, and reviewers
  • Approved claim, denial, and supporting source records
  • Applicable payer context and source-use permissions
  • A representative evaluation set and baseline process

What we evaluate

  • Denial-to-response time and total administrative effort
  • Source support, material corrections, and learning on a separate evaluation set where scoped
  • Exact-packet approval and changed-packet reapproval
  • Payer-pattern reporting and historical reimbursement baselines

Proposed deliverables

  • A jointly agreed scope and frozen evaluation criteria
  • Comparative response-time, effort, and quality findings
  • A scoped payer-pattern report, exceptions, and integration needs
  • An economic assessment and expand, revise, or stop decision

Development status and boundaries

The proposed platform draws on patent-pending technology disclosed in a U.S. provisional application. The initial pilot evaluates a limited workflow, with its scope agreed before engagement.

The current starting point uses synthetic records and a simulated payer. Adaptive learning and payer reporting are development objectives. Partner integration, production readiness, and financial benefit remain to be established. Faster reimbursement requires outcome data from a separately authorized prospective phase. Pilot fees, access, data handling, and success criteria require written agreement. Live effects are outside the initial evaluation unless separately authorized after readiness review.

Start with a scoping conversation.

Kevin Freels, MD · Founder & CEO
kfreels@claimfortistechnologies.com

Request a discussion